Kisspeptin-10 vs Sermorelin

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Kisspeptin-10Sermorelin
CategoryPeptidesPeptides
Standard DoseResearch indicates 1-10 mcg/kg via subcutaneous injection or IV bolus for acute HPG axis stimulation.Research indicates 200-300 mcg administered once daily at bedtime via subcutaneous injection.
TimingMorning dosing preferred for testosterone optimization. Can be used acutely before sexual activity.Bedtime administration (aligns with natural nocturnal GH release). On empty stomach.
Cycle DurationShort-term use only. Continuous kisspeptin administration may cause tachyphylaxis (desensitization) of the HPG axis.12-24 week cycles. Some protocols use continuous treatment.
Evidence Levelmoderate_humanstrong_human
A

Kisspeptin-10

Peptides

Mechanism

Kisspeptin-10 is the 10-amino acid C-terminal fragment of the kisspeptin family that signals directly to GnRH neurons through the kisspeptin receptor (KISS1R/GPR54), triggering GnRH release into the portal circulation. This stimulates LH and FSH secretion from anterior pituitary gonadotrophs. In men, intravenous kisspeptin-10 produces rapid dose-dependent LH rises (4.1 to 12.4 IU/L at 1 mcg/kg within 30 minutes), increases LH pulse frequency and amplitude, and subsequently elevates testosterone through the HPG axis.

Standard Dosing

Research indicates 1-10 mcg/kg via subcutaneous injection or IV bolus for acute HPG axis stimulation.

Timing

Morning dosing preferred for testosterone optimization. Can be used acutely before sexual activity.

Cycle Duration

Short-term use only. Continuous kisspeptin administration may cause tachyphylaxis (desensitization) of the HPG axis.

Side Effects

  • Facial flushing
  • Mild nausea
  • Elevated LH/testosterone (desired effect)
  • Potential for HPG axis desensitization with prolonged use

Contraindications

  • Hormone-sensitive cancers (prostate, breast)
  • Pregnancy and breastfeeding
  • Children/adolescents (premature puberty risk)

Best Stacking Partners

PT-141HCG
B

Sermorelin

Peptides

Mechanism

Sermorelin is a synthetic 29-amino acid peptide representing the biologically active fragment of GHRH (amino acids 1-29) with full functional activity. It activates GHRH receptors on pituitary somatotrophs, stimulating cAMP production via Gs protein/adenylate cyclase and MAP kinase pathways. Due to the interactive effects of sermorelin and endogenous somatostatin, GH release is episodic rather than continuous. Sermorelin also stimulates pituitary gene transcription of GH mRNA, increasing and preserving pituitary GH reserve.

Standard Dosing

Research indicates 200-300 mcg administered once daily at bedtime via subcutaneous injection.

Timing

Bedtime administration (aligns with natural nocturnal GH release). On empty stomach.

Cycle Duration

12-24 week cycles. Some protocols use continuous treatment.

Side Effects

  • Injection site reactions
  • Facial flushing
  • Headache
  • Dizziness
  • Transient taste changes

Contraindications

  • Active cancer
  • Pregnancy and breastfeeding
  • Intracranial hypertension

Best Stacking Partners

IpamorelinGHRP-2GHRP-6

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →